Sequana Medical NV
XBRU:SEQUA
Sequana Medical NV
XBRU:SEQUA
Price:
0.958
EUR
0.84%
Market Closed
Market Cap:
50.2m
EUR
Income Statement
Earnings Waterfall
Sequana Medical NV
Sequana Medical NV
|
Revenue
|
433.5k
EUR
|
|
Cost of Revenue
|
-4.1m
EUR
|
|
Gross Profit
|
-3.6m
EUR
|
|
Operating Expenses
|
-19.4m
EUR
|
|
Operating Income
|
-23m
EUR
|
|
Other Expenses
|
-4.1m
EUR
|
|
Net Income
|
-27.2m
EUR
|
Income Statement
Sequana Medical NV
Sequana Medical NV
Currency: EUR
Millions
TTM
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue |
1
N/A
|
1
+20%
|
1
-21%
|
1
+19%
|
1
-16%
|
0
-59%
|
0
-5%
|
1
+119%
|
1
+14%
|
1
-9%
|
1
-15%
|
0
-39%
|
|
| Gross Profit | |||||||||||||
| Cost of Revenue |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(4)
|
|
| Gross Profit |
(0)
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-187%
|
(1)
-93%
|
(2)
-86%
|
(2)
-49%
|
(2)
-1%
|
(2)
+0%
|
(3)
-39%
|
(4)
-23%
|
(4)
+13%
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(11)
|
(17)
|
(13)
|
(16)
|
(17)
|
(18)
|
(20)
|
(22)
|
(26)
|
(27)
|
(25)
|
(19)
|
|
| Selling, General & Administrative |
(6)
|
(10)
|
(7)
|
(7)
|
(6)
|
(6)
|
(7)
|
(8)
|
(9)
|
(9)
|
(9)
|
(8)
|
|
| Other Operating Expenses |
(5)
|
(7)
|
(7)
|
(9)
|
(10)
|
(12)
|
(13)
|
(14)
|
(17)
|
(18)
|
(16)
|
(11)
|
|
| Operating Income |
(11)
N/A
|
(17)
-61%
|
(13)
+22%
|
(16)
-20%
|
(17)
-8%
|
(20)
-13%
|
(23)
-14%
|
(24)
-6%
|
(28)
-17%
|
(30)
-8%
|
(29)
+5%
|
(23)
+20%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
|
| Non-Reccuring Items |
(2)
|
(2)
|
(1)
|
0
|
(0)
|
(1)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
(14)
N/A
|
(21)
-48%
|
(15)
+28%
|
(17)
-15%
|
(19)
-11%
|
(21)
-12%
|
(23)
-9%
|
(26)
-12%
|
(30)
-17%
|
(32)
-5%
|
(32)
0%
|
(27)
+16%
|
|
| Net Income | |||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(14)
|
(21)
|
(15)
|
(17)
|
(19)
|
(21)
|
(24)
|
(27)
|
(31)
|
(32)
|
(33)
|
(27)
|
|
| Net Income (Common) |
(14)
N/A
|
(21)
-48%
|
(15)
+27%
|
(17)
-15%
|
(19)
-11%
|
(21)
-12%
|
(24)
-10%
|
(27)
-13%
|
(31)
-16%
|
(32)
-5%
|
(33)
-1%
|
(27)
+17%
|
|
| EPS (Diluted) |
-1.11
N/A
|
-1.72
-55%
|
-1.22
+29%
|
-1.12
+8%
|
-1.25
-12%
|
-1.19
+5%
|
-1.3
-9%
|
-1.22
+6%
|
-1.35
-11%
|
-1.14
+16%
|
-1.22
-7%
|
-0.75
+39%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
